UPDF AI

Identification and Validation of Biomarkers in Metabolic Dysfunction‐Associated Steatohepatitis Using Machine Learning and Bioinformatics

Yuying Zhang,Jin’e Li,4 Authors,Jianping Liu

2025 · DOI: 10.1002/mgg3.70063
Molecular Genetics & Genomic Medicine · 1 Citations

Abstract

The incidence of metabolic dysfunction‐associated steatohepatitis (MASH) is increasing annually. MASH can progress to cirrhosis and hepatocellular carcinoma. However, the early diagnosis of MASH is challenging.